Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FC9S8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,822
Award facts
- Contract value 100% obligated
- $1,822.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $1,822.28 to AmerisourceBergen Drug Corp for ZEPBOUND 12.5 mg/0.5 mL pen injections on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and specifies performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, maintains a substantial portfolio of federal medical supply contracts with the Defense Logistics Agency and other government healthcare systems. The company's federal contracting demonstrates extensive capability across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. This delivery order for ZEPBOUND, a diabetes medication, exemplifies the company's critical role in supplying pharmaceutical products to support Defense Health Agency and military healthcare operations through flexible and competitively awarded contract vehicles.
Quick answers
Who was awarded contract SPE2DB25FC9S8?
SPE2DB25FC9S8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FC9S8 worth?
The government has obligated $1,822 on SPE2DB25FC9S8.
Is contract SPE2DB25FC9S8 an order under another contract?
Yes. SPE2DB25FC9S8 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FC9S8 competed?
The extent of competition for SPE2DB25FC9S8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award